PA
BATRA icon

PharVision Advisers’s Atlanta Braves Holdings Series A BATRA Stock Holding History

PharVision Advisers’s Portfolio BATRA Stock Details BATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,024
Closed -$410K – 707
2025
Q3 		$410K Buy
+9,024
New +$427K 0.23% 74

Other funds holding BATRA

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return

PharVision Advisers's BATRA Position: Q4 2025 in Review

PharVision Advisers sold out of Atlanta Braves Holdings Series A (BATRA) in Q4 2025, closing a stake of 9,024 shares — an estimated $410K sold.

PharVision Advisers first reported a position in BATRA in Q3 2025 and held it in 1 quarter. The position peaked at $410K in Q3 2025. 184 funds tracked by Wall St. Rank hold BATRA as of Q4 2025.

  • PharVision Advisers reported no remaining Atlanta Braves Holdings Series A position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 9,024 Atlanta Braves Holdings Series A shares in Q4 2025, an estimated $410K.
  • PharVision Advisers first reported a position in Atlanta Braves Holdings Series A in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Atlanta Braves Holdings Series A position peaked at $410K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series A as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.